南方医科大学学报 ›› 2026, Vol. 46 ›› Issue (2): 286-292.doi: 10.12122/j.issn.1673-4254.2026.02.06

• • 上一篇    

黄芪总苷通过抑制P38通路缓解氧糖剥夺/复氧后的星形胶质细胞水肿并降低AQP4表达

尹钦(), 雷雨逍, 王晓澍, 杨刚, 唐兆华()   

  1. 重庆医科大学第一附属医院神经外科,重庆 400016
  • 收稿日期:2025-06-16 出版日期:2026-02-20 发布日期:2026-03-10
  • 通讯作者: 唐兆华 E-mail:12728150@qq.com;drtzh01@outlook.com
  • 作者简介:尹 钦,硕士,住院医生,E-mail: 12728150@qq.com
  • 基金资助:
    国家自然科学基金(81301630);重庆市自然科学基金一般项目(cstc2021jcyj-msxmX0262);重庆医科大学未来医学青年创新计划(W0106)

Total Astragalus saponins reduce astrocyte swelling and AQP4 expression following oxygen-glucose deprivation and reoxygenation by inhibiting the p38 pathway

Qin YIN(), Yuxiao LEI, Xiaoshu WANG, Gang YANG, Zhaohua TANG()   

  1. Department of Neurosurgery, First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
  • Received:2025-06-16 Online:2026-02-20 Published:2026-03-10
  • Contact: Zhaohua TANG E-mail:12728150@qq.com;drtzh01@outlook.com
  • Supported by:
    National Natural Science Foundation of China(81301630)

摘要:

目的 探讨黄芪总苷(AST)对氧糖剥夺/复氧(OGD/R)诱导的星形胶质细胞肿胀的影响及其潜在分子机制。 方法 取2 d龄SD大鼠的乳鼠,共48只,随机分为4组,12只/组。从乳鼠大脑中提取原代星形胶质细胞,经OGD/R诱导损伤后,分别给予AST或AST联合P38激动剂U-46619处理。实验设置对照组、OGD/R组、AST组以及AST+U-46619组。其中,AST组在OGD/R处理前及过程中用AST处理细胞;AST+U-46619组在OGD/R处理前及过程中用AST和U-46619共同处理细胞。通过细胞体积检测、形态观察、活性氧物质(ROS)检测和乳酸脱氢酶(LDH)活性测定评估各组细胞的肿胀、ROS水平和损伤程度;采用免疫荧光共聚焦显微镜显示细胞膜上水通道蛋白4(AQP4)的蛋白表达情况;Western blotting检测P38信号通路的磷酸化水平及细胞膜上AQP4蛋白的表达水平。 结果 与OGD/R组相比,AST处理降低了OGD/R损伤引起的星形胶质细胞体积增加(P<0.05)、ROS水平(P<0.05)和LDH释放量(P<0.05),改善了细胞形态变化,抑制了细胞膜上AQP4的过度聚集,降低了P38的磷酸化水平(P<0.05)和细胞膜上AQP4蛋白表达(P<0.05)。然而,U-46619与AST联合处理可逆转AST对细胞体积、形态、LDH水平、P38磷酸化和AQP4表达水平的影响(均P<0.05)。 结论 AST缓解OGD/R后星形胶质细胞水肿,其分子机制可能为抑制细胞中ROS产生和抑制P38信号通路激活,从而降低了AQP4在细胞膜上过度表达。

关键词: 黄芪总苷, 星形胶质细胞肿胀, 水通道蛋白4, P38, 氧糖剥夺/复氧

Abstract:

Objective To investigate the effect of total Astragalus saponins (AST) on astrocyte swelling induced by glucose-oxygen deprivation and reoxygenation (OGD/R) and its molecular mechanism. Methods Primary astrocytes isolated from the brain of post-natal day 2 SD rats were treated with solvent vehicle, AST, or AST combined with U-46619 (a p38 activator) 24 h prior to and during exposure to OGD/R. The changes in cell volume and morphology were observed, and intracellular reactive oxygen species (ROS) levels and lactate dehydrogenase (LDH) activity were detected. The expression of aquaporin 4 (AQP4) on cell membrane was observed using immunofluorescence confocal microscopy, and Western blotting was performed to detect the changes in p38 signaling pathway phosphorylation levels and AQP4 expression level. Results AST treatment significantly reduced OGD/R-induced increase in astrocyte volume, ROS levels and LDH release. The AST-treated cells also exhibited improved cell morphology, reduced aggregation of AQP4 on the cell membrane, and decreased p38 phosphorylation and AQP4 expression levels. The protective effects of AST against OGD/R-induced cell injuries were significantly attenuated by combined treatment of the cells with U-46619. Conclusion AST alleviate astrocyte swelling induced by OGD/R injury by inhibiting the activation of the p38 signaling pathway and AQP4 overexpression on the cell membrane.

Key words: total Astragalus glycosides, astrocyte swelling, aquaporin 4, p38 signaling pathway, oxygen-glucose deprivation/reoxygenation